ABANDONED - NO STATEMENT OF USE FILED
no statement of use filed
on 27 Mar 2023
Last Applicant/ Owned by
451 D Street, Suite 104
Boston
MA
02210
Serial Number
90342754 filed on 25th Nov 2020
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
DEWPOINTX
Pharmaceutical preparations and therapeutic agents for use in wound healing, for use in the treatment of women's health conditions in the nature of uterine fibroids and Polycystic Ovary Syndrome (PCOS), and for use in the treatment and prevention of neurodegenerative diseases, cancer, metabolic disease, auto-immune diseases, inflammation, infectious disease, prion-based diseases, cardiovascular di Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations and therapeutic agents for use in wound healing, for use in the treatment of women's health conditions in the nature of uterine fibroids and Polycystic Ovary Syndrome (PCOS), and for use in the treatment and prevention of neurodegenerative diseases, cancer, metabolic disease, auto-immune diseases, inflammation, infectious disease, prion-based diseases, cardiovascular diseases, renal disease, pulmonary diseases, neurological disease, fibrosis, liver diseases; reagents for medical use
Mark Details
Serial Number
No 90342754
Mark Type
No Service/Collective Mark
Attorney Docket Number
No D09062000101
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 27th Mar 2023 | ABANDONMENT - NO USE STATEMENT FILED |
| 27th Mar 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 16th Aug 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 12th Aug 2022 | SOU TEAS EXTENSION RECEIVED |
| 12th Aug 2022 | SOU EXTENSION 2 FILED |
| 12th Aug 2022 | SOU EXTENSION 2 GRANTED |
| 17th Feb 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 15th Feb 2022 | SOU TEAS EXTENSION RECEIVED |
| 15th Feb 2022 | SOU EXTENSION 1 FILED |
| 15th Feb 2022 | SOU EXTENSION 1 GRANTED |